Abstract. Nowadays, there are many ways to administer the huge variety of drugs that are on the market. A drug is a chemical substance, that when applied to a living creature, alters its body function. Many drugs are used daily, such as caffeine in coffee and aspirin for pain. A route of drug administration in pharmacology and toxicology is the path by which a drug is brought into contact with the body. The most critical issue is some drugs are not significantly absorbed into the bloodstream. There are thousands of questions on the drug diffusion in the bloodstream and the most common issue is how long will these micro particles drug be released from the tablet? Thus, to identify the rate of the drug release and to control the drug release in our body is important, where to meet the target and not to become a waste. The Computational Fluid Dynamics method was used to investigate the drug design and diffusion profiles with time during the process of degradation and diffusion in water.
Introduction
The effectiveness of these drugs, however, is often limited by side effects or the necessity to administer the compound in a clinical setting, the goal in designing sustained or controlled delivery system is to reduce the frequency of dosing or to increase effectiveness of the drug by localization at the site of action, reducing the dose required, or providing uniform drug delivery. Sustained release constitutes any dosage form that provides medication over and extended time. Controlled release, however, denotes that the system is able to provide some actual therapeutic control, whether this is of a temporal nature, spatial nature or both. The design and investigation of active agent delivery systems is a multidisciplinary area which has attracted interest from various investigators over the last two decades.
The traditional delivery systems are characterized by immediate and uncontrolled release kinetics of the delivered active agent. The drug release for example, usually undergoes a sharp increase in concentration followed by a similar decrease in concentration that may causes a dangerous approach to the toxic threshold or fall down below the effective therapeutic level [1] . The purpose of the contemporary delivery systems, or so called controlled release systems is to maintain the agent concentration in the target medium at a desired value and to assure a control of the release rate and of the duration of the agent [2] . Currently, the process for controlled drug release systems is of critical importance for the implementation of contemporary therapeutic treatment, which places a stress on drug effectiveness and patient compliance. Thus, for the drug design to be more effective in a control release system brings engineers and pharmacists to work together with a common aim.
Time-controlled drug delivery can be achieved through polymeric drug delivery systems, using the widely accepted biodegradable polymer PLGA -Poly (Lactide-co-glycolide) acid [3] . The chemical structure of poly(lactide-co-glycolide)acid is illustrated in Figure 1 and Figure 2 depicted one of the example biodegradable micro particle of 60:40 lactide:glycolide PLGA. Two promising candidates among the PLGA-based polymeric drug delivery systems include micro particles and nanoparticles containing the active pharmaceutical agent encapsulated in PLGA matrix. PLGA-based micro particles have been studied extensively and several products are available on the market [4] . However, for site-specific controlled drug delivery, nanoparticles offer additional advantages due to their submicron size, which makes extravasations possible and occlusion of terminal blood vessels unlikely [5] . While the drug release behaviour has been studied for PLGA based micro particles and nanoparticles encapsulating various hydrophobic drugs [6] , there have been few attempts to develop a systematic methodology to understand and modulate the drug release profile. Previous attempts to tailor the release profiles include that of [7] , who utilized polymer and micro particle blending to achieve desired release profiles for a system of peptide-loaded PLGA micro particles. They blended PLGA polymers of different molecular weights to make micro particles and also produced peptide loaded micro particles from different molecular weight PLGA. This is a good strategy to control the drug release from a micro particulate system since the drug release is affected by diffusion as well as polymer degradation and the latter is strongly affected by polymer molecular weight. The primary objective of this study is to investigate drug release profiles in water (H 2 O) by using Computational Fluid Dynamics (CFD) software which is CFX-Multiphysics (version 12) codes. This is realized by first interpreting the effect of nanoparticles of drug location in the coated polymer (PLGA) and drug diffusion rate which is taken from an in vitro study. CFD is a sophisticated mathematical analysis technique used for predicting the behaviour of fluid in the flow field of interest, heat and mass transfer, phase change, chemical reaction, mechanical movement and even the stresses or deformation of related solid structures. CFD studies can provide superior visualization that would not be available through conventional laboratory experiments. Consequently, better and faster development (or analysis) will lead to shorter design cycles and compress the time between the conceptual stage and field implementation. This will clearly be advantageous in the diagnosis and troubleshooting of existing equipment, evaluating retrofit designs, and hence minimizing down time. Most importantly, it is apparent that process optimization will result in a substantial saving of time and expense.
Methodology
In the CFX-Multiphysics codes, there are a few procedures that need to be followed and the material properties need to be well defined. The fluid domain is assigned to the water phase (continuous phase) while the porous domain is assigned to PLGA and PLGA with the drug (linamarin) (dispersed solid). A monolithic system was used in this study where the active agent will be dispersed or dissolved in an inert polymer, and its release, controlled by the diffusivity of the drug. The specific components used were pure water, Linamarin and 80:20 Poly (lactide-coglycolide) acid (PLGA). The water properties are defined in the material library, however, Linamarin properties needed to be self-defined in the material library, which is assumed to be similar to water properties as depicted in Table 1 . In this study, there are a few limitation, which were only one micro particles of PLGA which coated the nanoparticles drug used inside, the degradation of PLGA did not occur in the time for this study, taken from 0 s to 20000 s. The analysis was run in the range between 0 s to 20000 s, which is in the burst curve in Figure 3 . The mass flux was scaled up to 10000, which became 7.164 10 -8 kg/m 2 s to shorten the running time of the analysis. Linamarin data were taken from a previous study on linamarin encapsulation [8] as shown in Figure  4 , then was converted to a ln graph as shown in Figure 5 . The slope of the graph was taken randomly at point 5 and 7, which gave a straight line. From the slope given, the linamarin mass transfer rate value is 7.164 10 -11 , which represents the diffusivity, D in units of kg/s. There is a limitation to calculate a linamarin mass flux, J value due to the size. Therefore, the mass flux was taken from a previous study [11] which is close to linamarin as depicted in Table 2 . Since the mass fluxes were in the range between 1 x 10 -12 to 9 x 10 -12 kg/m 2 s , therefore, the linamarin mass flux value was assumed to have the same mass flux range. In this study, the process of diffusion is described by a series of equations governed by Fick's First Law of diffusion. By trial and error calculations, to achieve the value of mass flux close to 7.164 10 -11 , due to limitations of time and workstation memory, the predicted partition coefficient values are between 0.05 to 0.15, as illustrated in Table 3 . As a result, the best value of K is 0.1 m 2 due to maintain the range of mass flux as given. By neglecting the degradation of 80:20 PLGA, its properties were not defined in the study, however, the porosity value needed to be defined which is 0.173, taken from a previous study [8] . Table 3 : Estimated partition coefficient value with different calculated mass flux.
In this study, three models were designed using ANSYS-CFX design modeler and investigated as follows:
Nanoparticles drug at the centre of PLGA known as MODEL A. The diameter of the PLGA is 1000 nm and the drug diameter is 160 nm as in Figure 6 . 
Results
The analysis was made from 0 s to 20000 s of drug release which is in the range of the burst effect curve as illustrated in Figure 3 , where the current results were expected of high drug release in the range of the burst area. Meanwhile, this study assumed degradation of PLGA did not occur during the nanoparticles of Linamarin drug being released since PLGA will degrade at a longer time than the analysis time (0-20000). Thus, the PLGA shape will remain the same.
At 5000 s, the nanoparticles of Linamarin have started releasing from the PLGA as illustrated in Figure 9 . Linamarin being released was slowly being forced out by water. The water gradually entered the PLGA at 15000 s and 20000 s, which showed more nanoparticles drug being released during this time. While entering the PLGA, the water also became the driving force for these controlled releases. The nanoparticles drug were being forced to be released at the bottom side of the PLGA meanwhile at the top surface water was replacing the drug. As mentioned earlier, in this model the nanoparticles of Linamarin drug were uniformly distributed in the PLGA. These nanoparticles of Linamarin drugs are expected to be released faster compared with Model A and C. As the results at 5000 s, the nanoparticles drug started being released at 10000 s, water gradually replaces nanoparticles of drug, which means during this time, more drugs will release. At 15000 s to 20000 s, the nanoparticles of drug in the PLGA were decreasing as it is being replaced by the water. At 20000 s, half of the PLGA is filled by the water, meanwhile the drug still continues being released but expected during this time the release rate becomes lower since only a few nanoparticles drug were left in the PLGA as illustrated in Figure 10 . For Model C as in Figure 11 , the nanoparticles of Linamarin were located at the surface of PLGA. These results showed the nanoparticles drug being released at the slowest rate compared to the other two models. At 5000 s, at the top section of PLGA, these nanoparticles of drug at the surface being forced to fill in the cavity in the PLGA. The highest drug released occurred only at the bottom section of the PLGA. The process was continued at 10000 s, many nanoparticles drug moved into the middle of the PLGA, the drug tend to release slower. At 15000 s to 20000 s more drug only is being released at the bottom portion of the PLGA, meanwhile at the top portion the nanoparticles drug continued moving into the middle portion.
(a) (b) Figure 11 : (a) 3D Model C and meshing generated from the simulation and (b) Contour plot of the nanoparticles drug at the centre of PLGA at 5000 s, 10000 s, 15000 s and 20000 s.
For these three models, results showed that the location of these nanoparticles of Linamarin also affect the drug control release. As the results, the Model B, which the nanoparticles of Linamarin were well distributed in the PLGA, released drug at the highest rate, meanwhile Model C results showed this model has the lowest rate of the drug release. Hence, the control release can be done better if these nanoparticles of drug can be placed at the location, which can bring the lowest rate of drug release.
Conclusion
This study has achieved the objective to get the profile of nanoparticles Linamarin drug controlled release from three different locations of drug in PLGA. Linamarin was used for this analysis, which it was assumed was coated with 80:20 PLGA with Model A nanoparticles drug at the centre of PLGA, Model B nanoparticles drug equally distributed in PLGA, Model C nanoparticles drug distributed only around PLGA. A few assumptions being made to simplify the model and to shorten the running time of the analysis without affecting the results. The time released was taken from 0 s to 20000 s, which is in the range of the burst effect curve. As a result, more nanoparticles Linamarin being released during a specific time which was proved in a result of these three models. This study gave a basic idea of the drug release profiles on how the location of these nanoparticles inside the PLGA can affect the rate release.
